Don't Be Too Quick to Jump on the Vascepa (Icosapent Ethyl) Bandwagon
You'll hear cautious optimism about cardiovascular benefits with the Rx omega-3 fatty acid, Vascepa (icosapent ethyl)...and see a flood of ads.
Vascepa is a form of EPA (eicosapentaenoic acid). Other Rx omega-3s (Lovaza) or fish oil supplements have EPA and DHA (docosahexaenoic acid).
New evidence suggests Vascepa 2 g BID may prevent a CV event in about one in 21 high-CV-risk patients over 5 years compared to placebo. This is in patients with elevated triglycerides of about 215 mg/dL despite statins...and CV disease OR diabetes plus other CV risks (high BP, etc).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote